Larvol Delta - A-Clinical-Study-of-Allogeneic-CD19BCMA-CART-Cells-for-the-Treatment-of-RR-Bcell-Malignant-Tumors

RN1101 - AlloRunning Therapeutics

http://clinicaltrials.gov/ct2/show/NCT06976437

Jul 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev